Delivery Order SPE2DB22D2206-SPE2DB25FKD69
Award Date 9/28/25
Potential Completion Date 10/20/25
Potential Value $18K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $35,554 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Enhertu 100 mg vials, with an ultimate completion date of September 25, 2025. This non-set-aside competitive award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive $999,999,999 pharmaceutical supply vehicle running through December 2026....
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Enhertu 100 mg vials, valued at $17,777.00, with a completion date of September 23, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $12,443.90 for 100 mg vials of Enhertu, a oncology therapeutic agent, with performance in Conshohocken, Pennsylvania and completion scheduled for May 13, 2025. This competitively awarded, firm fixed-price delivery order contains no set-aside designation and represents a child contract under AmerisourceBergen's larger pharmaceutical supply framework with the federal government. This delivery order executes...
- The Defense Logistics Agency awarded a $14,221.60 delivery order to AmerisourceBergen Drug Corp for 100 mg vials of Enhertu, a specialized oncology medication, with performance at the contractor's Conshohocken, Pennsylvania location. The contract is structured as a firm fixed-price delivery order under a non-competitive set-aside, with an ultimate completion date of October 3, 2025. This award represents a child contract issued against AmerisourceBergen's larger Indefinite Delivery Contract...
- AmerisourceBergen Drug Corp received a $17,777 firm fixed price delivery order from the Defense Logistics Agency (DLA) on September 23, 2025, for 100 mg vials of Enhertu, a oncology pharmaceutical product. The contract, with an ultimate completion date of October 15, 2025, represents a direct delivery order without a set-aside designation, awarded through competitive procedures. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $10,666.20 delivery order to AmerisourceBergen Drug Corp for 100 mg vials of Enhertu, a oncology therapeutic agent, with performance in Conshohocken, Pennsylvania and completion targeted for June 13, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The delivery order represents a single transaction under AmerisourceBergen's larger Indefinite Delivery Contract vehicle with DLA Troop Support Medical (SPE2DX), a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Enhertu 100 mg vials, a specialty oncology pharmaceutical. This firm fixed-price delivery order, valued at $8,888.50 with an ultimate completion date of August 20, 2025, represents a non-competitive set-aside transaction under AmerisourceBergen's existing contract vehicle. The pharmaceutical will be delivered to the company's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $17,777 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 100 mg vials of Enhertu, a oncology therapeutic agent used in cancer treatment. The contract was competitively awarded without set-aside restrictions and carries an ultimate completion date of September 24, 2025. AmerisourceBergen will perform this delivery order from its corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a...
- The Defense Logistics Agency awarded a delivery order valued at $8,888.50 to AmerisourceBergen Drug Corp for the supply of Enhertu 100 mg vials, with an ultimate completion date of October 7, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded on September 16, 2025. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $17,777.00 to AmerisourceBergen Drug Corp for 100 mg vials of Enhertu, a oncology medication used in cancer treatment. This firm fixed price delivery order, awarded on August 19, 2025, with a completion date of September 10, 2025, represents a competitive award with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order operates...